Bixiye
QP39-20 Commercial Pharmacy Benefit Exclusion for Beovu®, Quzyttir™, Reblozyl®, Recarbrio™ and Vyepti™
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 08, 2020
Natiijooyinka Raadinta
Soo bandhiga 2481 - 2490 ee natiijooyinka 3698
Bixiye
P21-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2020
Bixiye
P23-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates – Effective June 1, 2020
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2020
Bixiye
P22-20 eviCore to Become Final Reviewer on Appeals for Commercial Members
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2020
Bixiye
QP42-20 Minnesota Health Care Programs: New Provider Website
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 22, 2020
Bixiye
QP40-20 Coding Tips for Psychological and Neuropsychological Testing
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 08, 2020
Bixiye
QP38-20 Pharmacy Benefit Exclusion for Consensi®
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 08, 2020
Bixiye
QP36-20 Pharmacy Benefit Exclusion for VyeptiTM and Sarclisa®
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 08, 2020
Bixiye
QP37-20 MHCP Pharmacy Benefit Exclusion for Beovu®, Quzyttir™, Reblozyl®, Recarbrio™, Ruxience™, Truxima® and Zirabev®
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 08, 2020
Bixiye
2020 March Provider Press
Taariikhda uu dhaqangalayo Barnaamijka: 24, Feb 2020